BiotechTube
CMIC

CMIC

New York, United States· Est.
en.cmicgroup.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

CMIC Group is a leading Asia-Pacific focused CRO and comprehensive pharmaceutical services provider, established as Japan's first and largest CRO. It provides a fully integrated suite of services spanning non-clinical research, clinical development (Phases I-IV), regulatory consulting, manufacturing, and post-marketing commercialization, with particular expertise in facilitating market entry into Japan. The company leverages its deep regional expertise and network across more than 12 APAC countries to support global clients in navigating complex regulatory landscapes and accelerating drug development.

OncologyOrphan DiseasesGeneral Medicine

Technology Platform

Integrated pharmaceutical services platform covering non-clinical CRO, clinical CRO (Phases I-IV), regulatory consulting, CDMO, and CSO functions, with deep regional expertise in Japan and APAC markets.

Opportunities

Capitalizing on the growing demand for APAC market entry support from Western biopharma, especially in the complex Japanese market.
Expansion of services for advanced therapies (cell/gene) and digital health platforms presents new growth vectors.

Risk Factors

High dependence on the APAC region subjects the business to local economic and regulatory shifts.
Faces intense competition from large global CROs and must continuously execute on its integrated service model to maintain its market position.

Competitive Landscape

Competes with large global full-service CROs (e.g., IQVIA, LabCorp, ICON, PPD) and other regional APAC-focused CROs. Its primary competitive advantage is its entrenched #1 position and deep local expertise in Japan, a market with significant barriers to entry for foreign firms.

More companies in Digital Health & Biotech SaaS →More companies in United States →